HC Wainwright reaffirmed their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. They currently have a $7.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other research firms have also […]
Daré Bioscience (NASDAQ:DARE – Get Rating) and Prothena (NASDAQ:PRTA – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends. Profitability This table compares Daré Bioscience and Prothena’s net margins, return […]
Form 8-K Flux Power Holdings, For: Apr 28 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Maxim Group began coverage on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a research report report published on Friday, Marketbeat reports. The brokerage issued a buy rating and a $4.00 target price on the biotechnology company’s stock. Other research analysts have also issued reports about the company. HC Wainwright lifted their target price […]
Daré Bioscience (NASDAQ:DARE – Get Rating) had its price target boosted by Roth Capital from $11.00 to $17.00 in a research report report published on Friday, The Fly reports. A number of other analysts also recently weighed in on DARE. Zacks Investment Research downgraded Daré Bioscience from a buy rating to a hold rating in […]